Abstract
Background and aims: To determine whether high levels of serum total cholesterol and low levels of high-density lipoprotein cholesterol (HDL-c) are associated with increased mortality in the elderly. Methods: Prospective cohort study of 1032 non-institutionalized people aged 70 in the city of Turku, Southern Finland. The cohort population was recruited as part of a larger longitudinal aging study, the Turku Elderly Study. Fasting serum levels of total cholesterol, HDL-c and triglycerides were measured, and the amount of low-density lipoprotein cholesterol was calculated at baseline. The cohort was followed for mortality for 12 years, and the causes of death were recorded and further classified into cardiovascular and other causes of death. The hazard ratios of dying for subjects in various cholesterol quartiles were computed by the Cox proportional hazards model, adjusting for cardiovascular risk factors and pre-existing medical conditions. Results: Low levels of serum total cholesterol and HDL-c were associated with a greater risk of death over a follow-up of 12 years. After adjustment for several cardiovascular risk factors, the association between total cholesterol and survival changed. All-cause mortality seemed to be highest in the highest quartile of total cholesterol and nearly as high in the lowest quartile of total cholesterol, suggesting a U-shaped connection, but the differences were not statistically significant. However, cardiovascular mortality was significantly lowest in the lowest quartile of total cholesterol and significantly highest in the lowest quartile of HDL-c. Conclusions: High levels of serum total cholesterol and particularly low levels of HDL-c seem to be risk factors for cardiovascular mortality even in the elderly population.
References
Stamler J, Stamler R, Neaton JD et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy. Findings for 5 large cohorts of young adult and middle-aged men and women. JAMA 1999; 282: 2012–8.
Guralnik JM, LaCroix AZ, Everett DF, Kovar MG. Aging in the eighties: the prevalence of comorbidity and its association with disability. In: Advance Data from Vital and Health Statistics of the National Center for Health Statistics, no. 170, Rockville, MD. U.S. Public Health Service, Health Resources Administration, 1989.
Fagot-Campagna A, Hanson RL, Narayan KMV, Sievers ML, Nelson RG, Knowler WC. Serum cholesterol and mortality rates in a Native American population with low cholesterol concentrations: a U-shaped association. Circulation 1997; 96: 1408–15.
Curb JD, Abbott RD, Rodriguez BL et al. Prospective association between low and high total and low-density lipoprotein cholesterol and coronary heart disease in elderly men. J Am Geriatr Soc 2004; 52: 1975–80.
Jacobs D, Blackburn H, Higgins M et al. Report on the conference on low blood cholesterol: mortality associations. Circulation 1992; 86: 1046–60.
Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med 1993; 153: 1065–73.
Brescianini S, Maggi S, Farchi G et al. Low total cholesterol and increased risk of dying: are low levels warning signs in the elderly? Results from the Italian Longitudinal Study on Aging. J Am Geriatr Soc 2003; 51: 991–6.
Weverling-Rijnsburger AWE, Blauw GJ, Lagaay AM, Knook DL, Meinders AE, Westendorp RGJ. Total cholesterol and risk of mortality in the oldest old. Lancet 1997; 350: 1119–23.
Volpato S, Leveille SG, Corti M-C, Harris TB, Guralnik JM. The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc 2001; 49: 1142–7.
Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 2001; 358: 351–5.
Corti M-C, Guralnik JM, Salive ME et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 1997; 126: 753–60.
Corti M-C, Guralnik JM, Salive ME et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 1995; 274: 539–44.
Schaefer EJ, Moussa PB, Wilson PW, McGee D, Dallai G, Castelli WP. Plasma lipoproteins in healthy octogenarians: lack of reduced high density lipoprotein cholesterol levels: results from the Framingham Heart Study. Metabolism 1989; 38: 293–6.
Weverling-Rijnsburger AW, Jonkers IJ, van Exel E, Gussekloo J, Westendorp RGJ. High-density vs low-density cholesterol as the risk factor for coronary heart disease and stroke in old age. Arch Intern Med 2003; 163: 1549–54.
Krumholz HM, Seeman TE, Merrill SS et al. Lack of association between cholesterol and cardiovascular disease mortality and all-cause mortality in persons older than 70 years. JAMA 1994; 272: 1335–40.
Chyou PH, Eaker ED et al. Serum cholesterol concentrations and all-cause mortality in older people. Age Ageing 2000; 29: 69–74.
Arve S, Tilvis RS, Lehtonen A, Valvanne J, Sairanen S. Coexistence of lowered mood and cognitive impairment of elderly people in five birth cohorts. Aging Clin Exp Res 1999; 11: 90–5.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
Folstein MF, Folstein SE, McHugh PR. Mini-Mental-State; a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189–98.
Panza F, Solfrizzi V, Colacicco AM et al. Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline. Aging Clin Exp Res 2006; 18: 144–8.
Reitz C, Tang M-X, Luchsinger J, Mayeux R. Relation of plasma lipids to Alzheimer’s disease and vascular dementia. Arch Neurol 2004; 61: 705–14.
Schupf N, Costa R, Luchsinger J, Tang M-X, Lee JH, Mayeux R. Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc 2005; 53: 219–26.
Schalk B, Visser M, Deeg D, Bouter ML. Lower levels of serum albumin and total cholesterol and future decline in functional performance in older persons: the Longitudinal Aging Study Amsterdam. Age Ageing 2004; 33: 266–72.
Hazzard WR. Depressed albumin and high-density lipoprotein cholesterol: signposts along the final common pathway of frailty. J Am Geriatr Soc 2001; 49: 1253–4.
Morley JE, Perry HM, Miller DK. Something about frailty. J Gerontol 2002; 57A: M698–704.
Reuben DB, Ix JH, Greendale GA, Seeman TE. The predictive value of combined hypoalbuminemia and hypercholesterolemia in high functioning community-dwelling older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 1999; 47: 402–6.
Iribarren C, Reed DM, Burchfiel CM, Dwyer JH. Serum total cholesterol and mortality: confounding factors and risk modification in Japanese-American men. JAMA 1995; 273: 1926–32.
Meilahn EN, Ferrell FE. Naturally occurring low blood cholesterol and excess mortality. Coron Artery Dis 1993; 4: 843–53.
Abbot RD, Yano K, Hakim AA et al. Changes in total and high-density lipoprotein cholesterol over 10- and 20-year periods (the Honolulu Heart Program). Am J Cardiol 1998; 82: 172–8.
Postiglione A, Cortese C, Fischetti A et al. Plasma lipids and geriatric assessment in a very aged population of South Italy. Atherosclerosis 1989; 80: 63–8.
Zuliani G, Romagnoni F, Bollini C, Leoci V, Soattin L, Fellin R. Low levels of high-density lipoprotein cholesterol are a marker of disability in the elderly. Gerontology 1999; 45: 317–22.
Zuliani G, Volpato S, Romagnoni F et al. Combined measurement of serum albumin and high-density lipoprotein cholesterol strongly predicts mortality in frail older nursing-home residents. Aging Clin Exp Res 2004; 16: 472–5.
Lehtimäki T, OJala P, Rontu R et al. Interleukin-6 modulates plasma cholesterol and c-reactive protein concentrations in nonagenarians. J Am Geriatr Soc 2005; 53: 1552–8.
Nikkilä M, Heikkinen J. Serum cholesterol, high-density lipoprotein cholesterol and five-year survival in elderly. Age Ageing 1990; 19: 403–8.
Packard CJ, Ford I, Robertson M et al. Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 2005; 112: 3058–65.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Upmeier, E., Lavonius, S., Lehtonen, A. et al. Serum lipids and their association with mortality in the elderly: a prospective cohort study. Aging Clin Exp Res 21, 424–430 (2009). https://doi.org/10.1007/BF03327441
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03327441